Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

An2 Therapeutics, Inc

Clinical trials sponsored by An2 Therapeutics, Inc, explained in plain language.

AN2 Therapeutics, Inc. ANTX NASDAQ

Clinical-stage biopharmaceutical company developing treatments for rare infectious diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Completed 1 Terminated 1

New hope for stubborn lung infection? trial of epetraborole begins, then stops

Disease control Terminated

This study tested an oral drug called epetraborole for people with a tough-to-treat lung infection called MAC lung disease. The trial aimed to see if adding epetraborole to standard treatment could improve symptoms and clear the infection. However, the study was terminated early,…

Phase: PHASE2, PHASE3 • Sponsor: AN2 Therapeutics, Inc • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC